105 related articles for article (PubMed ID: 4030937)
1. Analysis of antitumour [1,1-bis(aminomethyl)cyclohexane]platinum(II) complexes derived from spiroplatin by high-performance liquid chromatography with differential pulse amperometric detection.
Elferink F; van der Vijgh WJ; Pinedo HM
J Chromatogr; 1985 Mar; 320(2):379-92. PubMed ID: 4030937
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of free and total platinum species after rapid and prolonged infusions of aqua (1,1-bis(aminomethyl)cyclohexane) sulfatoplatinum (II) (spiroplatin) during a phase I trial.
van der Vijgh WJ; Elferink F; Vermorken JB; ten Bokkel Huinink WW; Klein I; Gall HE; Simonetti G; McVie JG; Pinedo HM
Eur J Cancer Clin Oncol; 1988 Apr; 24(4):621-7. PubMed ID: 3383966
[TBL] [Abstract][Full Text] [Related]
3. Influence of hydrolysis products of aqua(1,1-bis(aminomethyl)cyclohexane)sulfatoplatinum(II) on toxicity in rats.
Elferink F; Van der Vijgh WJ; Van der Poort SE; Henzen-Logmans SC; Pinedo HM
Cancer Lett; 1984 Nov; 25(1):61-9. PubMed ID: 6542826
[TBL] [Abstract][Full Text] [Related]
4. Determination of ethylenediamineplatinum(II) malonate in infusion fluids, human plasma and urine by high-performance liquid chromatography.
van der Vijgh WJ; Elferink F; Postma GJ; Vermorken JB; Pinedo HM
J Chromatogr; 1984 Oct; 310(2):335-42. PubMed ID: 6511851
[TBL] [Abstract][Full Text] [Related]
5. A sensitive postcolumn derivatization/UV detection system for HPLC determination of antitumor divalent and quadrivalent platinum complexes.
Kizu R; Yamamoto T; Yokoyama T; Tanaka M; Miyazaki M
Chem Pharm Bull (Tokyo); 1995 Jan; 43(1):108-14. PubMed ID: 7895301
[TBL] [Abstract][Full Text] [Related]
6. Biliary excretion of platinum in rats after administration of cisplatin and aqua(1,1-bis(aminomethyl)-cyclohexane)sulfatoplatinum(II) (spiroplatin, TNO-6).
Van der Vijgh WJ; Verbeek PC; Klein I; Pinedo HM
Cancer Lett; 1985 Aug; 28(1):103-9. PubMed ID: 4040805
[TBL] [Abstract][Full Text] [Related]
7. On-line differential pulse polarographic detection of carboplatin in biological samples after chromatographic separation.
Elferink F; van der Vijgh WJ; Pinedo HM
Anal Chem; 1986 Sep; 58(11):2293-6. PubMed ID: 3532865
[No Abstract] [Full Text] [Related]
8. High-performance liquid chromatographic procedures for the analysis of carboplatin in human plasma and urine.
Gaver RC; Deeb G
Cancer Chemother Pharmacol; 1986; 16(3):201-6. PubMed ID: 3516429
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of reductive amperometric detection in the liquid chromatographic determination of antineoplastic platinum complexes.
Bannister SJ; Sternson LA; Repta AJ
J Chromatogr; 1983 Apr; 273(2):301-18. PubMed ID: 6683277
[TBL] [Abstract][Full Text] [Related]
10. Determination of cisplatin and related platinum complexes in plasma ultrafiltrate and urine by high-performance liquid chromatography with on-line radioactivity detection.
Baldew GS; Volkers KJ; De Goeij JJ; Vermeulen NP
J Chromatogr; 1989 Jun; 491(1):163-74. PubMed ID: 2793971
[TBL] [Abstract][Full Text] [Related]
11. Metabolic studies of an orally active platinum anticancer drug by liquid chromatography-electrospray ionization mass spectrometry.
Poon GK; Raynaud FI; Mistry P; Odell DE; Kelland LR; Harrap KR; Barnard CF; Murrer BA
J Chromatogr A; 1995 Sep; 712(1):61-6. PubMed ID: 8556156
[TBL] [Abstract][Full Text] [Related]
12. High-performance liquid chromatographic determination of cisplatin as platinum(II) in a pharmaceutical preparation and blood samples of cancer patients.
Khuhawar MY; Lanjwani SN; Memon SA
J Chromatogr B Biomed Sci Appl; 1997 May; 693(1):175-9. PubMed ID: 9200532
[TBL] [Abstract][Full Text] [Related]
13. Determination of platinum-containing drugs in human plasma by liquid chromatography with reductive electrochemical detection.
Parsons PJ; Morrison PF; LeRoy AF
J Chromatogr; 1987 Jan; 385():323-35. PubMed ID: 3558589
[TBL] [Abstract][Full Text] [Related]
14. A validated liquid chromatography/tandem mass spectrometry assay for cis-amminedichloro(2-methylpyridine)platinum(II) in human plasma ultrafiltrate.
Oe T; Tian Y; O'Dwyer PJ; Roberts DW; Malone MD; Bailey CJ; Blair IA
Anal Chem; 2002 Feb; 74(3):591-9. PubMed ID: 11838680
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of a novel platinum anticancer compound HJ5 by high performance liquid chromatography].
Liu Y; He J; Liu ZD; Chen XZ; Liu WP
Se Pu; 2002 Jul; 20(4):345-7. PubMed ID: 12541919
[TBL] [Abstract][Full Text] [Related]
16. Analysis of platinum species originating from cis-diamminedichloroplatinum(II) (cisplatin) in human and rat plasma by high-performance liquid chromatography with on-line inductively coupled plasma atomic emission spectrometric detection.
de Waal WA; Maessen FJ; Kraak JC
J Chromatogr; 1987 Oct; 407():253-72. PubMed ID: 3429508
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of a new platinum compound, cis-(glycolato-O,O) [(4R,5R)-4,5-bis(aminomethyl)-1,3-dioxolane-2-spiro-1'-cyclohexane]plat inum (II) in dogs.
Kim DK; Cho YB; Kim HT; Kim TS; Kim KH; Hong WS
Anticancer Res; 1996; 16(3A):1167-9. PubMed ID: 8702230
[TBL] [Abstract][Full Text] [Related]
18. A validated inductively coupled plasma mass spectrometry (ICP-MS) method for the quantification of total platinum content in plasma, plasma ultrafiltrate, urine and peritoneal fluid.
Lemoine L; Thijssen E; Noben JP; Adriaensens P; Carleer R; Speeten KV
J Pharm Biomed Anal; 2018 Apr; 152():39-46. PubMed ID: 29414017
[TBL] [Abstract][Full Text] [Related]
19. Determination of cis-diamminedichloroplatinum(II) in human plasma using ion-pair chromatography with electrochemical detection.
Parsons PJ; LeRoy AF
J Chromatogr; 1986 Jun; 378(2):395-408. PubMed ID: 3733997
[TBL] [Abstract][Full Text] [Related]
20. Uptake and metabolism of iproplatin in murine L1210 cells.
Pendyala L; Walsh JR; Huq MM; Arakali AV; Cowens JW; Creaven PJ
Cancer Chemother Pharmacol; 1989; 25(1):15-8. PubMed ID: 2590997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
